Whitelab Genomics
Series AParis, FranceSep 2022
Whitelab Genomics raised €9.8M in a Series A round in Sep 2022. The company is based in Paris, France. Investors in the round: Debiopharm Innovation Fund, Omnes Capital. Data as of 4 Nov 2026.
Amount raised
€9.8M
€9,828,010
Native amount
10,000,000 USD
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
10,000,000 USD
ECB-at-date → €9.8M · rate 1.0175 on 2022-09-13
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Sep 2022
Round type
series a
Amount (EUR)
€9.8M
Other rounds
same companyRelated news
- Whitelab Genomics Raises $10M in Series A Fundingfinsmes.com · 2022-09